Stem cell therapy, in which the patient receives his or her own cells, slips through the cracks of regulations.
AI-driven approach could revolutionize treatment with faster diagnoses.
Massive funding cuts for research & development in proposed budget.
Biocomputers could give a boost to precision in medicine with a new wave of cell-based therapies.
The uninsured, the health-illiterate, women, minorities and immigrants constitute the under-represented sections in the datasets.
One of the benefits of such 3D-imagery is that it cuts short the surgical time as surgeons are aware of what to expect.
Genetically engineered red blood cells that can be loaded up with therapeutic proteins in patients battling cancer and other rare conditions.
The outcome of the highly risky and complicated surgery can be gauged only after a few weeks.
Breakthrough may simplify precision drug delivery inside the human body.
The highly personalized treatment also called “living drug” sources immune cells from the patient.
